Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study-Reference-Cited by-同舟云学术

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

Published:2018-06-24 Issue:9 Volume:41 Page:1970-1980
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Buse John B.^ORCID,Garg Satish K.,Rosenstock Julio^ORCID,Bailey Timothy S.,Banks Phillip,Bode Bruce W.^ORCID,Danne Thomas^ORCID,Kushner Jake A.^ORCID,Lane Wendy S.,Lapuerta Pablo,McGuire Darren K.,Peters Anne L.,Reed John,Sawhney Sangeeta,Strumph Paul

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. The Emerging Role Of Adjunctive Noninsulin Antihyperglycemic Therapy In The Management Of Type 1 Diabetes

2. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

3. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

4. Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

5. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta‐analysis of randomized controlled studies examining the effects of sodium‐glucose co‐transporter‐2 inhibitors on peripheral artery disease and risk of amputations;Diabetes, Obesity and Metabolism;2024-09-12

2. Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin;Diabetes Technology & Therapeutics;2024-09-01

3. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association;Diabetes & Metabolism Journal;2024-07-31

4. A Review of Sotagliflozin: The First Dual SGLT-1/2 Inhibitor;Cardiology in Review;2024-07-29

5. SGLT2i effect on atrial fibrillation: A network meta‐analysis of randomized controlled trials;Journal of Cardiovascular Electrophysiology;2024-06-28